Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors

2018 ◽  
Vol 65 (9) ◽  
pp. e27226 ◽  
Author(s):  
Marco Russo ◽  
Pasqualino Malandrino ◽  
Mariacarla Moleti ◽  
Francesco Vermiglio ◽  
Antonio D'Angelo ◽  
...  
2018 ◽  
Vol 64 (2) ◽  
pp. 159-165
Author(s):  
Mikhail Fridman ◽  
Svetlana Mankovskaya ◽  
Olga Krasko

Among the factors determining the relapse/persistence of papillary thyroid cancer in children and adolescents the most important are the age of the patient (p= 0.003), the presence of concomitant background pathology (p


2017 ◽  
Vol 8 (2) ◽  
pp. 64-70
Author(s):  
Christopher Thompson ◽  
Iain J Nixon

ABSTRACT Through significant contributions to our understanding of risk factors, prognostic indicators and management of well-differentiated thyroid cancer (WDTC), Prof Jatin Shah has contributed much to the field of thyroid cancer in recent times. Many of the guidelines used in WDTC management today are a testament to his less-aggressive, dedicated and individualised approach. This article seeks to both review the current understanding of WDTC and to outline these contributions in a special issue dedicated to the career of Prof Shah. How to cite this article Thompson C, Nixon IJ. Our Understanding of Well-differentiated Thyroid Cancer. Int J Head Neck Surg 2017;8(2):64-70.


Author(s):  
G. Cortês Nascimento ◽  
A. G. P. de Araujo Cortês Nascimento ◽  
C. de Maria Ribeiro Veiga Parente ◽  
V. P. Rodrigues ◽  
R. S. de Sousa Azulay ◽  
...  

2015 ◽  
Vol 30 (4) ◽  
pp. 543 ◽  
Author(s):  
Tom Edward Ngo Lo ◽  
Abigail Uy Canto ◽  
Patricia Deanna D. Maningat

2008 ◽  
Vol 50 (6) ◽  
pp. 1159-1162 ◽  
Author(s):  
Prasad T. Oommen ◽  
Annika Romahn ◽  
Tobias Linden ◽  
Michael C. Frühwald ◽  
Peter Bucsky

2020 ◽  
Vol 13 (2) ◽  
pp. 111-117
Author(s):  
Wan Wook Kim ◽  
Jeeyeon Lee ◽  
Jin Hyang Jung ◽  
Ho Yong Park ◽  
Ji Yun Jeong ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-6 ◽  
Author(s):  
Guadalupe Vargas-Ortega ◽  
Lourdes Balcázar-Hernández ◽  
Baldomero González-Virla ◽  
Claudia Ramírez-Rentería ◽  
Oriana Nieto-Guzmán ◽  
...  

Background. The primary hyperparathyroidism (PHPT) is a common disease for the endocrinologist. The concomitant thyroid disease and differentiated thyroid cancer (DTC) appear to be more frequent in patients with PHPT than in the general population. The aim of this study was to characterize patients with symptomatic PHPT with and without DTC and analyze frequency and risk factors.Methods. We consecutively studied patients with symptomatic PHPT diagnosed and treated at our center between 2013 and 2015. Patients with subclinical and syndromic forms of PHPT were excluded. Clinical and biochemical characteristics of patients with and without DTC were compared and risk factors were determined. All patients were studied with thyroid ultrasound and thyroid gammagraphy with TC-MIBI. Two expert surgeons performed all the surgical procedures.Results. In 59 patients included, we found 12 cases of PTC (20.3%). The final histopathological report of the PTC was 7 cases of follicular variant, 2 cases of oncocytic variant, 2 cases of classic variant, and 1 case of columnar cells variant of PTC. Patients with thyroid cancer were older than patients without thyroid cancer (62 ± 9.5 versus 52 ± 15.8, p = 0.03). Higher preoperative levels of iPTH were associated with PTC (p=0.03) [OR 5.16 (95% CI: 1.08-24.7)].Conclusion. PTC is frequent in patients with symptomatic PHPT. Thyroid nodules in patients with symptomatic PHPT must be studied before parathyroidectomy. In symptomatic PHPT, higher level concentration of parathormone (PTH) was associated with higher risk of DTC.


Sign in / Sign up

Export Citation Format

Share Document